We only have this paper's title and publication details.
Read it at the sourceEditorial commentary on docetaxel's efficacy alongside androgen therapies and androgen deprivation in metastatic prostate cancer, suggesting important treatment implications.
The author declares no conflicts of interest.
No takes yet. Share an insight, caveat, or question.
Seiji Arai (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: